Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology?

Current Opinion in Obstetrics and Gynecology

Volumn 21, Issue 3, 2009, Pages 285-290

  Vercammen, Martine ^a,b   Verloes, An ^a   Haentjens, Patrick ^b,c,d   Van De Velde, Hilde ^e  

^a Laboratory of Haematology   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d Belgian Center for Evidence Based Medicine   (Belgium)

^e CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Clinical pregnancy; Infertility treatment; Soluble human leucocyte antigen G

Indexed keywords

HLA G ANTIGEN;

EMBRYO CULTURE; GENE ACTIVATION; HUMAN; IMMUNOASSAY; INFERTILITY THERAPY; NIDATION; OOCYTE; OVARY FOLLICLE FLUID; PREDICTION; PREGNANCY; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

BIOLOGICAL MARKERS; COCULTURE TECHNIQUES; CULTURE MEDIA; EMBRYO CULTURE TECHNIQUES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 67650300493     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32832924cd     Document Type: Review

References (71)

1. della RT, Verheyen G, Papanikolaou EG, et al. Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer. Reprod Biol Endocrinol 2007; 5:2.
2. Papanikolaou EG, Camus M, Kolibianakis EM, et al. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 2006; 354:1139-1146.
3. Hamel M, Dufort I, Robert C, et al. Identification of differentially expressed markers in human follicular cells associated with competent oocytes. Hum Reprod 2008; 23:1118-1127.
4. Butcher L, Coates A, Martin KL, et al. Metabolism of pyruvate by the early human embryo. Biol Reprod 1998; 58:1054-1056.
5. Leese HJ, Sturmey RG, Baumann CG, McEvoy TG. Embryo viability and metabolism: obeying the quiet rules. Hum Reprod 2007; 22:3047-3050.
6. Singh R, Sinclair KD. Metabolomics: approaches to assessing oocyte and embryo quality. Theriogenology 2007; 68 (Suppl 1):S56-S62.
7. Vergouw CG, Botros LL, Roos P, et al. Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, noninvasive method for embryo selection. Hum Reprod 2008; 23:1499-1504.
8. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertil Steril 2006; 86:678-685.
9. Hunt JS, Langat DK, McIntire RH, Morales PJ. The role of HLA-G in human pregnancy. Reprod Biol Endocrinol 2006; 4 (Suppl 1):S10.
10. Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:1065-1074.
11. Le Bouteiller P, Fons P, Herault JP, et al. Soluble HLA-G and control of angiogenesis. J Reprod Immunol 2007; 76:17-22.
12. Fuzzi B, Rizzo R, Criscuoli L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311-315.
13. Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008; 14:209-218.
14. Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A 1987; 84:9145-9149.
15. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992; 89:3947-3951.
16. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994; 153:5516-5524.
17. Kirszenbaum M, Moreau P, Gluckman E, et al. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994; 91:4209-4213.
18. Moreau P, Carosella E, Teyssier M, et al. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol 1995; 43:231 -236.
19. Paul P, Cabestre FA, Ibrahim EC, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000; 61:1138-1149.
20. Park GM, Lee S, Park B, et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 2004; 313:606-611.
21. Hviid TV, Moller C, Sorensen S, Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 1998; 59:87-98.
22. Juch H, Blaschitz A, Daxbock C, et al. A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains. J Immunol Methods 2005; 307:96-106.
23. Boyson JE, Erskine R, Whitman MC, et al. Disulfide bond-mediated dimeriza-tion of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002; 99:16180-16185.
24. Gonen-Gross T, Achdout H, Gazit R, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol 2003; 171:1343-1351.
25. Carosella ED, Favier B, Rouas-Freiss N, et al. Beyond the increasing complex- ity of the immunomodulatory HLA-G molecule. Blood 2008; 111:4862-4870.
26. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod 1995; 10 (Suppl 2):14 - 21.
27. Blaschitz A, Lenfant F, Mallet V, et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997; 27:3380-3388.
28. McMaster M, Zhou Y, Shorter S, et al. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998; 160:5922-5928.
29. Jurisicova A, Casper RF, MacLusky NJ, et al. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 1996; 93:161 -165.
30. Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil Steril 1996; 65:997-1002.
31. Hammer A, Hutter H, Dohr G. HLA class I expression on the materno-fetal interface. Am J Reprod Immunol 1997; 38:150-157.
32. Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005; 175:8379-8385.
33. Shaikly VR, Morrison IE, Taranissi M, et al. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J Immunol 2008; 180:4330-4337.
34. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and mye-lomonocytic cells. J Exp Med 1997; 186:1809-1818.
35. Bahri R, Hirsch F, Josse A, et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006; 176:1331-1339.
36. Le Rond S, AzemaC, Krawice-Radanne I, et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 2006; 176:3266-3276.
37. Colonna M, Samaridis J, Cella M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160:3096-3100.
38. Cooper MA, FehnigerTA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
39. Goodridge JP, Witt CS, Christiansen FT, Warren HS. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003; 171:1768-1774.
40. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003; 171:3415-3425.
41. Rajagopalan S, Bryceson YT, Kuppusamy SP, et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006; 4:e9.
42. Goldman-Wohl DS, Ariel I, Greenfield C, et al. HLA-G expression in extra-villous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol Hum Reprod 2000; 6:535-540.
43. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of preeclampsia: a case-control study using family triads. Mol Hum Reprod 2004; 10:237-246.
44. Roberts JM,TaylorCT, Melling GC, et al. Expression oftheCD46 antigen, and absence of class I MHC antigen, on the human oocyte and preimplantation blastocyst. Immunology 1992; 75:202-205.
45. Guzeloglu-Kayisli O, Pauli S, Demir H, et al. Identification and characterization of human embryonic poly(A) binding protein (EPAB). Mol Hum Reprod 2008; 14:581 -588.
46. Braude P, Bolton V, Moore S. Human gene expression first occurs between the four- and eight-cell stages of preimplantation development. Nature 1988; 332:459-461.
47. Rizzo R, Fuzzi B, Stignani M, et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? J Reprod Immunol 2007; 74:133-142.
48. Ledee N, Thonon F, Perrier d'Hauterieve S, et al. Significance of soluble HLA-G detection in follicular fluids and embryo supernatants in IVF/ICSI cycles. Am J Reprod Immunol 2007; 57:411.
49. Tabiasco J, Perrier d'Hauterieve S, Thonon F, et al. Soluble HLA-G in IVF-/ ICSI-embryo culture supernatants does not always predict implantation success: a multicenter study. RBM Online 18:374-381.
50. Noci I, Fuzzi B, Rizzo R, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod 2005; 20:138-146.
51. Rebmann V, SwitalaM, Eue I, et al. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol 2007; 68:251 -258.
52. Warner CM, Lampton PW, Newmark JA, Cohen J. Symposium: innovative techniques in human embryo viability assessment. Soluble human leukocyte antigen-G and pregnancy success. Reprod Biomed Online 2008; 17:470-485.
53. SherG, KeskintepeL, Nouriani M, et al. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency' and IVF outcome. Reprod Biomed Online 2004; 9:74-78.
54. Sher G, Keskintepe L, Batzofin J, et al. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: a prospective study. Hum Reprod 2005; 20:1359-1363.
55. Sher G, Keskintepe L, Fisch JD, et al. Soluble human leukocyte antigen G expression in phase I culture media at 46 h after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil Steril 2005; 83:1410-1413.
56. Fisch JD, Keskintepe L, Ginsburg M, et al. Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer. Fertil Steril 2007; 87:757-763.
57. Criscuoli L, Rizzo R, Fuzzi B, et al. Lack of histocompatibility leukocyte antigen-G expression in early embryos is not related to germinal defects or impairment of interleukin-10 production by embryos. Gynecol Endocrinol 2005; 20:264-269.
58. Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reprod Biomed Online 2006; 13:272-277.
59. Sageshima N, Shobu T, Awai K, et al. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods. J Reprod Immunol 2007; 75:11 -22.
60. Yie SM, Balakier H, Motamedi G, Librach CL. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril 2005; 83:30-36.
61. Sallam H, El-Kassar Y, Hany Abdella Rahman A, et al. Glucose consumption and total protein production by preimplantation embryos in pregnant and nonpregnant women: possible methods for embryo selection. Fertil Steril 2006; 86 (supplement 2):884.
62. Menezo Y, Elder K, Viville S. Soluble HLA-G release by the human embryo: an interesting artefact? Reprod Biomed Online 2006; 13:763-764.
63. Pouletty P, Ferrone S, Amesland F, et al. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens 1993; 42:45-54.
64. Rebmann V, LeMaoult J, Rouas-Freiss N, et al. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol 2005; 66:853-863.
65. Rebmann V, van der Ven K, Passler M, et al. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57:15-21.
66. Ober C, Aldrich C, Rosinsky B, et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19:127-132.
67. MenierC, Riteau B, Dausset J, et al. HLA-G truncated isoformscan substitute for HLA-G1 in fetal survival. Hum Immunol 2000; 61:1118-1125.
68. Casro MJ, Morales P, Rojo-Amigo R, et al. Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival. Tissue Antigens 2000; 56:232-239.
69. Noriko S, Hirotsugu H, Masanori Y, et al. Are in vitro fertilized eggs able to secrete HLA-G? Am J Reprod Immunol 2004; 52:8.
70. JaeschkeR, GuyattGH,Sackett DL. Users'guides to the medical literature. III: How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271:703-707.
71. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, editors. Systemic reviews in healthcare: meta-analysis in context. 2nd ed. BMJ 2001:285-312.